CAS 2348493-39-8

NUC-7738

CAS : 2348493-39-8

NUC-7738

Degré de pureté : ≥95%

Masse moléculaire : 568.52g/mol

Ref: 54-BUP21703

NUC-7738

CAS : 2348493-39-8

NUC-7738 is a medicinal compound that has been shown to be an effective inhibitor of cyclin-dependent kinases (CDKs). It has potent anticancer activity and has been studied extensively in Chinese hamster ovary (CHO) cells, human leukemia cells, and other cancer cell lines. NUC-7738 works by selectively inhibiting CDK4/6, which are critical regulators of the cell cycle. This leads to the induction of apoptosis in cancer cells, making it a promising new therapeutic agent for the treatment of various types of cancer. Additionally, NUC-7738 has been shown to have low toxicity and good pharmacokinetic properties in preclinical studies. Overall, this compound holds great promise as a novel anticancer therapy that may help improve outcomes for patients with cancer.

Formule : C₂₆H₂₉N₆O₇P

Degré de pureté : Min. 95%

Masse moléculaire : 568.5 g/mol

Ref: 3D-YTD49339

NUC-7738

CAS : 2348493-39-8

NUC-7738 is a 5'-aryloxyphosphoamidoester prodrug of 3'-dA, which regulates 尾-catenin signaling and can be used in cancer research.

Formule : C₂₆H₂₉N₆O₇P

Degré de pureté : 97.32% - 97.32%

Couleur et forme : Solid

Masse moléculaire : 568.52

Ref: TM-T78516